Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

invendo submits 510(k) application to US FDA

This article was originally published in Clinica

Executive Summary

invendo medical has filed a 510(k) submission with the US FDA seeking market clearance of the company’s C20 colonoscopy system and SC20 single-use colonoscope. The approval application – the firm's first in the US – is based on results from a pivotal trial in 61 subjects, results from which appeared two months ago (www.clinica.co.uk, 5 January 2010). In the trial, lesions were detected in 41% of the subjects, and there were no device-related adverse events. The C20 system is already CE marked in Europe. invendo is based in New York and Kissing, Germany.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel